Finanzen von Thermogenesis Holdings Inc (THMO)THMOThermogenesis Holdings Inc

Thermogenesis Holdings Inc (THMO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is AXP, accounting for 71.8% of total sales, equivalent to $1.96M. Other significant revenue streams include BioArchive and CAR-TXpress. Understanding this composition is critical for investors evaluating how THMO navigates market cycles within the Office Equipment industry.

Evaluating the bottom line, Thermogenesis Holdings Inc maintains a gross margin of 43.92%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -20.35%, while the net margin is -73.11%. These profitability ratios, combined with a Return on Equity (ROE) of -417.94%, provide a clear picture of how effectively THMO converts its operational activities into shareholder value.

In the context of the broader market, THMO competes directly with industry leaders such as NAOV and DYNT. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, THMO's gross margin of 43.92% stands against NAOV's 26.18% and DYNT's 26.06%. Such benchmarking helps identify whether Thermogenesis Holdings Inc is trading at a premium or discount relative to its financial performance.